Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer

被引:9
|
作者
Kim, Hwanik [1 ]
Lussier, Yves A. [2 ,3 ,4 ]
Noh, O. Kyu [1 ,2 ,3 ,4 ]
Li, Haiquan [2 ,3 ,4 ]
Oh, Young-Taek [1 ]
Heo, Jaesung [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Radiat Oncol, Suwon 441749, South Korea
[2] Univ Arizona, Dept Med, Tucson, AZ USA
[3] Univ Arizona, Inst BIO5, Tucson, AZ USA
[4] Univ Arizona, Leon Levy Canc Ctr, Tucson, AZ USA
关键词
Non-small cell lung cancer; Postoperative radiotherapy; Pulmonary function; Prognostic factor; END RESULTS DATABASE; RADIATION-THERAPY; STAGE-II; SURVIVAL; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; CHEMOTHERAPY; METAANALYSIS; MORTALITY;
D O I
10.1016/j.radonc.2014.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to investigate the prognostic effect of pulmonary function at the beginning of postoperative radiotherapy (PORT) in non-small cell lung cancer (NSCLC). Materials and methods: From January 2002 to December 2012, 115 patients with NSCLC who underwent PORT and took the forced expiratory volume in 1 second (FEV1) at the beginning of PORT were analysed. PORT began within 4-6 weeks following surgery, and the 3-dimensional conformal technique was used with conventional fractionation. The high and low FEV1 groups were divided by the median absolute value of FEV1 at the beginning of PORT, and we compared the clinical factors and survival between two groups. Results: The median absolute value of FEV1 at the beginning of PORT was >= 1.68 L (range, 0.83-3.89), and patients were divided into low and high FEV1 groups (<1.68 L versus 1.68 L). Patients in the low FEV1 group showed a lower preoperative FEV1 (mean, 1.94 L versus 2.73 L, p < 0.001) and received more pneumonectomy (36.8% versus 8.6%, p < 0.001) compared to the high FEV1 group. The overall median follow-up time was 31 months (range, 3-110), and 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS) and overall survival (OS) were 52.4%, 48.9%, and 45.9%, respectively. Five-year OS of the low FEVI group was significantly lower than that of the high FEVI group (35.4% versus 56.9%, p = 0.002), and no significant differences were found in LRRFS and DMFS. In a multivariate analysis, the difference of OS between the low and high FEV1 groups remained significant (Hazard Ratio = 2.04, Cl, 1.18-3.55, p = 0.011). Conclusions: The FEV1 at the beginning of PORT was an independent significant prognostic factor in patients with NSCLC who received PORT. Considering this analysis was limited to only patients receiving PORT, further studies are warranted to compare the survival effect of postoperative pulmonary function between groups with/without PORT. (C) 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc- nd/3.0/).
引用
收藏
页码:374 / 378
页数:5
相关论文
共 50 条
  • [41] Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer
    Takamori, Shinkichi
    Tagawa, Tetsuzo
    Toyokawa, Gouji
    Shimokawa, Mototsugu
    Kinoshita, Fumihiko
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Akamine, Takaki
    Hirai, Fumihiko
    Honda, Hiroshi
    Maehara, Yoshihiko
    [J]. ANNALS OF THORACIC SURGERY, 2020, 109 (03): : 914 - 920
  • [42] Postoperative Irradiation in Non-Small Cell Lung Cancer
    Hoecht, Stefan
    Heide, Juergen
    Bischoff, Ronald
    Gruendel, Olaf
    Carstens, Detlef
    [J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 145 - 149
  • [43] Postoperative chemotherapy in non-small cell lung cancer
    Milleron, B.
    Gounant, V.
    Giroux-Leprieur, E.
    Lavole, A.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S64 - S68
  • [44] Non-small cell lung cancer.: Survival after radiotherapy and prognostic factors
    Olasolo, JJ
    Redondo, EA
    Jiménez, AL
    Ramos, AR
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (02): : 81 - 86
  • [45] Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
    Kaul, David
    Angelidis, Alexander
    Budach, Volker
    Ghadjar, Pirus
    Kufeld, Markus
    Badakhshi, Harun
    [J]. RADIATION ONCOLOGY, 2015, 10
  • [46] Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients
    Zhao, Hong-Yun
    Ma, Guo-Wei
    Zou, Ben-Yan
    Li, Mei
    Lin, Su-Xia
    Zhao, Li-Ping
    Guo, Ying
    Huang, Yan
    Tian, Ying
    Xie, Dan
    Zhang, Li
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 1301 - 1310
  • [47] Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
    David Kaul
    Alexander Angelidis
    Volker Budach
    Pirus Ghadjar
    Markus Kufeld
    Harun Badakhshi
    [J]. Radiation Oncology, 10
  • [48] Analysis for prognostic factors of postoperative stage I non-small cell lung cancer
    Park, C
    Park, H
    Keum, D
    Kang, Y
    Han, S
    [J]. LUNG CANCER, 2005, 49 : S358 - S358
  • [49] Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Sugio, Kenji
    Mizukami, Makiko
    Ichiki, Yoshinobu
    Sugaya, Masakazu
    Yasuda, Manabu
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1127 - 1132
  • [50] Prognostic factors for nivolumab monotherapy in postoperative recurrence of non-small cell lung cancer
    Inoue, Takashi
    Ishihama, Hiromi
    Tachibana, Taimei
    Imamura, Nobuhiro
    Nonaka, Yuuto
    Ito, Yoshiyuki
    Araki, Osamu
    Sumiko, Maeda
    Chida, Masayuki
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S334 - S334